AIPILL Trademark

Trademark Overview


On Friday, April 14, 2023, a trademark application was filed for AIPILL with the United States Patent and Trademark Office. The USPTO has given the AIPILL trademark a serial number of 79374188. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 5, 2024. This trademark is owned by Shanghai Biotech application Co., Ltd.. The AIPILL trademark is filed in the Medical Instrument Products category with the following description:

Apparatus for use in medical analysis, namely, medical diagnostic instruments for the analysis of body fluids; medical apparatus and instruments, namely, endoscopy apparatus and instruments for use in endoscopy procedures; telemetry devices for medical applications; intracranial pressure measuring equipment; nanorobots for medical purposes, namely, targeted drug delivery, treating cancer; medical capsule endoscope; Wearable medical biometric data monitor for medical or diagnostic use; diabetic monitoring apparatus, namely, blood glucose meters; medical devices for introducing pharmaceutical preparations into human body, namely, infusion and injection devices for administering drugs; medical ultrasound apparatus.
aipill

General Information


Serial Number79374188
Word MarkAIPILL
Filing DateFriday, April 14, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkARTIFICIAL INTELLIGENCE PILL
Pseudo MarkAI PILL
Goods and ServicesApparatus for use in medical analysis, namely, medical diagnostic instruments for the analysis of body fluids; medical apparatus and instruments, namely, endoscopy apparatus and instruments for use in endoscopy procedures; telemetry devices for medical applications; intracranial pressure measuring equipment; nanorobots for medical purposes, namely, targeted drug delivery, treating cancer; medical capsule endoscope; Wearable medical biometric data monitor for medical or diagnostic use; diabetic monitoring apparatus, namely, blood glucose meters; medical devices for introducing pharmaceutical preparations into human body, namely, infusion and injection devices for administering drugs; medical ultrasound apparatus.

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, July 14, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShanghai Biotech application Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Friday, July 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 13, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, July 18, 2023APPLICATION FILING RECEIPT MAILED
Thursday, January 11, 2024ASSIGNED TO EXAMINER
Friday, January 19, 2024NON-FINAL ACTION WRITTEN
Saturday, January 20, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 6, 2024REFUSAL PROCESSED BY MPU
Tuesday, February 6, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 27, 2024REFUSAL PROCESSED BY IB
Tuesday, August 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 7, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, August 7, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, August 6, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 6, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 5, 2024NON-FINAL ACTION WRITTEN